The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis

Q2 Medicine Obesity Medicine Pub Date : 2024-09-01 DOI:10.1016/j.obmed.2024.100551
Hessam Yaghmaei , Seyed Ali Nojoumi , Masood Soltanipur , Hossein Yarmohammadi , Seyed Mohsen Mirhosseini , Mahdi Rezaei , Mohammadreza Jalali Nadoushan , Seyed Davar Siadat
{"title":"The role of gut microbiota in non-alcoholic fatty liver disease pathogenesis","authors":"Hessam Yaghmaei ,&nbsp;Seyed Ali Nojoumi ,&nbsp;Masood Soltanipur ,&nbsp;Hossein Yarmohammadi ,&nbsp;Seyed Mohsen Mirhosseini ,&nbsp;Mahdi Rezaei ,&nbsp;Mohammadreza Jalali Nadoushan ,&nbsp;Seyed Davar Siadat","doi":"10.1016/j.obmed.2024.100551","DOIUrl":null,"url":null,"abstract":"<div><p>Non-alcoholic fatty liver disease (NAFLD) is on the rise globally, both in adults and children. The \"multiple-hits\" hypothesis presents that various factors simultaneously impact the formation of NAFLD, one of which is gut microbiota (GM). Following damage to the intestinal barrier by dysbiosis, which increases permeability, the liver is constantly exposed to bacteria and related products. There is growing evidence that microbial metabolites may contribute to the pathogenicity of NAFLD. The pathogenic mechanisms of GM in NAFLD are not precisely known but gut dysbiosis appears to be associated with the development of NAFLD. In this article, we intend to review the probable mechanisms of GM pathogenesis in NAFLD.</p></div>","PeriodicalId":37876,"journal":{"name":"Obesity Medicine","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Obesity Medicine","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2451847624000216","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Non-alcoholic fatty liver disease (NAFLD) is on the rise globally, both in adults and children. The "multiple-hits" hypothesis presents that various factors simultaneously impact the formation of NAFLD, one of which is gut microbiota (GM). Following damage to the intestinal barrier by dysbiosis, which increases permeability, the liver is constantly exposed to bacteria and related products. There is growing evidence that microbial metabolites may contribute to the pathogenicity of NAFLD. The pathogenic mechanisms of GM in NAFLD are not precisely known but gut dysbiosis appears to be associated with the development of NAFLD. In this article, we intend to review the probable mechanisms of GM pathogenesis in NAFLD.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肠道微生物群在非酒精性脂肪肝发病机制中的作用
非酒精性脂肪肝(NAFLD)在全球范围内呈上升趋势,无论是成人还是儿童。多重打击 "假说认为,多种因素同时影响非酒精性脂肪肝的形成,其中之一是肠道微生物群(GM)。肠道屏障因菌群失调而受到破坏,渗透性增加,肝脏就会不断接触到细菌和相关产物。越来越多的证据表明,微生物代谢产物可能是非酒精性脂肪肝的致病因素。非酒精性脂肪肝中转基因的致病机制尚不确切,但肠道菌群失调似乎与非酒精性脂肪肝的发生有关。在本文中,我们将回顾非酒精性脂肪肝中转基因致病的可能机制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Obesity Medicine
Obesity Medicine Medicine-Public Health, Environmental and Occupational Health
CiteScore
5.50
自引率
0.00%
发文量
74
审稿时长
40 days
期刊介绍: The official journal of the Shanghai Diabetes Institute Obesity is a disease of increasing global prevalence with serious effects on both the individual and society. Obesity Medicine focusses on health and disease, relating to the very broad spectrum of research in and impacting on humans. It is an interdisciplinary journal that addresses mechanisms of disease, epidemiology and co-morbidities. Obesity Medicine encompasses medical, societal, socioeconomic as well as preventive aspects of obesity and is aimed at researchers, practitioners and educators alike.
期刊最新文献
Sorghum bicolor polyphenol-rich extract improves insulin sensitivity and protect against chronic stress exacerbated diabetic nephropathy through modulation of Nrf2/NF-κB Swimming exercise regulates indices of skeletal muscle glucose metabolism and attenuates cardiac inflammatory cytokines activity via IL-6/TNF-α pathway in streptozotocin-induced diabetic rats Sestrin2 at the crossroads of cardiovascular disease and diabetes: A comprehensive review Three scientists on GLP-1 based obesity drug development are sharing 2024 Lasker-DeBakey Clinical Research Award Erratum to “Effect of low-calorie ketogenic vs low-carbohydrate diets on body composition and other biomarkers of overweight/obese women: An 8 weeks randomised controlled trial” [Obes. Med. 41C (2023) 100496]
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1